Tenax Therapeutics (TENX)
10.77
+0.22 (2.09%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
June 5, 2026 11:41 AM - SEC Filing
Form 8-K TENAX THERAPEUTICS, INC. For: Jun 02
June 4, 2026 4:10 PM - SEC Filing
Piper Sandler Sees Sees a 'compelling buying opportunity' in Tenax Therapeutics (TENX)
June 1, 2026 8:06 AM - StreetInsider
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC
May 20, 2026 5:05 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Logos Global Management LP
May 15, 2026 6:56 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Stonepine Capital Management, LLC
May 15, 2026 5:29 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
May 15, 2026 4:39 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 4:35 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP
May 15, 2026 4:20 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:20 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP
May 15, 2026 10:36 AM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP
May 15, 2026 8:38 AM - SEC Filing
Form 4 TENAX THERAPEUTICS, INC. For: May 11 Filed by: STAAB THOMAS R II
May 13, 2026 5:08 PM - SEC Filing
Form 3 TENAX THERAPEUTICS, INC. For: May 11 Filed by: STAAB THOMAS R II
May 13, 2026 4:57 PM - SEC Filing
Form S-8 TENAX THERAPEUTICS, INC.
May 12, 2026 5:01 PM - SEC Filing
Form 10-Q TENAX THERAPEUTICS, INC. For: Mar 31
May 12, 2026 4:07 PM - SEC Filing
Form 8-K TENAX THERAPEUTICS, INC. For: May 12
May 12, 2026 8:00 AM - SEC Filing
Tenax Therapeutics (TENX) Misses Q1 EPS by 35c
May 12, 2026 7:21 AM - StreetInsider
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
May 8, 2026 6:19 PM - SEC Filing
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
May 7, 2026 11:05 AM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
May 7, 2026 10:31 AM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Invus Global Management, LLC
May 4, 2026 2:47 PM - SEC Filing
Tenax Therapeutics names Timothy Healey as chief commercial officer
May 4, 2026 7:00 AM - StreetInsider
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
May 4, 2026 7:00 AM - Globe NewsWire
Form ARS TENAX THERAPEUTICS, INC. For: Dec 31
April 22, 2026 8:22 AM - SEC Filing
Form DEFA14A TENAX THERAPEUTICS, INC.
April 22, 2026 8:20 AM - SEC Filing
Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 17
April 22, 2026 8:18 AM - SEC Filing
Form 8-K TENAX THERAPEUTICS, INC. For: Apr 22
April 22, 2026 8:01 AM - SEC Filing
Tenax Therapeutics names Thomas Staab as chief financial officer
April 22, 2026 7:00 AM - StreetInsider
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
April 22, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: MORGAN STANLEY
April 8, 2026 6:26 PM - SEC Filing
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
April 7, 2026 9:35 PM - SEC Filing
Form EFFECT TENAX THERAPEUTICS, INC.
April 2, 2026 6:07 AM - SEC Filing
Form S-3 TENAX THERAPEUTICS, INC.
March 24, 2026 11:42 AM - SEC Filing
Cantor Fitzgerald Starts Tenax Therapeutics (TENX) at Overweight
March 17, 2026 6:11 AM - StreetInsider
Full Article List
